Core needle biopsy and subsequent parotidectomy demonstrated typical histologic features of Warthin’s tumor along with a low-level (8%-9%) CD5- and CD23-positive B-cell population consistent with chronic lymphocytic leukemia (CLL)-type monoclonal B-cell lymphocytosis (MBL). This evidence concerns the gene FCER2 and Warthin tumor.